BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 2413974)

  • 1. Mexiletine: long-term efficacy and hemodynamic actions in patients with ventricular arrhythmia.
    Sami M; Lisbona R
    Can J Cardiol; 1985; 1(4):251-8. PubMed ID: 2413974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)].
    Bellocci F; Ansalone G; Scabbia E; Santarelli P; Lucente M; Affinito V; Loperfido F; Zecchi P
    G Ital Cardiol; 1981; 11(4):488-97. PubMed ID: 6169580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-arrhythmic effects of mexiletine].
    Ledain L; Page A; Favreau L; Besse P
    Arch Mal Coeur Vaiss; 1982 May; 75(5):605-12. PubMed ID: 6180692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mexiletine therapy of ventricular extrasystoles in the acute phase of myocardial infarction].
    Juillard A; Bouajina A; Barrillon A; Gay J; Gerbaux A
    Ann Cardiol Angeiol (Paris); 1984; 33(2):117-20. PubMed ID: 6201121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mexiletine in the treatment of ventricular arrhythmias (author's transl)].
    Schlemmer M; Wimmer M
    Padiatr Padol; 1982; 17(2):383-9. PubMed ID: 6179031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mexiletine in patients with progressive infarction and reduced ventricular function: anti-arrhythmic efficacy and hemodynamic effects].
    Zacà F; Ghinelli M; Bombardini T; De Collibus C; Zaccaria O; Steffanon L; Azzolini U; Valentini P; Puddu P
    G Ital Cardiol; 1990 Jun; 20(6):569-75. PubMed ID: 2227228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias].
    Rolli A; Bonatti V; Finardi A; Favaro L; Botti G
    G Ital Cardiol; 1981; 11(4):468-76. PubMed ID: 6169578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mexiletine in the treatment of ventricular arrhythmias.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine].
    Zehender M; Geibel A; Hust M; Hohnloser S; Meinertz T; Just H
    Z Kardiol; 1987 Aug; 76(8):501-6. PubMed ID: 2445118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of rhythm disorders of ventricular origin with KO 1173 (Mexiletin) (author's transl)].
    Esser H; Kikis D
    Med Klin; 1977 Sep; 72(35):1386-91. PubMed ID: 71652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
    Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
    Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of ventricular arrhythmias with oral mexiletine.
    Talbot RG; Julian DG; Prescott LF
    Am Heart J; 1976 Jan; 91(1):58-65. PubMed ID: 53994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of mexiletine in ventricular arrhythmias among patients in Taiwan: assessment by 24-hour Holter electrocardiography.
    Hwang YS; Wang JL
    Clin Ther; 1989; 11(3):392-7. PubMed ID: 2743373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
    Lotto A; Finzi A; Massari FM; Pagnoni F; Valentini R; Ambrosini F; Lo Masto M
    G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mexiletine in the management of ventricular dysrhythmias.
    Campbell NP; Pantridge JF; Adgey AA
    Eur J Cardiol; 1977 Dec; 6(4):245-58. PubMed ID: 590296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mexiletine in the treatment of lidocaine-resistant ventricular tachycardia. Preliminary results].
    Santinelli V; Chiariello M; Stanislao M; Turco P; Clarizia M; Condorelli M
    G Ital Cardiol; 1982; 12(6):457-9. PubMed ID: 7160572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.
    Aguglia F; Gnecchi M; De Marzio P
    Int J Cardiol; 1985 Mar; 7(3):303-6. PubMed ID: 2579918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early interruption of antiarrhythmia treatment in the acute phase of infarction complicated by ventricular arrhythmia].
    Sebbah J; Khemache A; Gryman R; Farinotti R; Guérot C; Valère PE
    Ann Cardiol Angeiol (Paris); 1985 Mar; 34(3):129-32. PubMed ID: 4004087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.